Natco Pharma

Sector: Healthcare | Industry: Drugs & Pharma
R 714.65 7.95  | 1.12% 63.65% 26.12 2,366.87
NSE Price: Apr 17 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Apr 17 714.65 7.95 1.12% 711.90 706.70 43,963 709.05 - 725.45
BSE Apr 17 715.65 9.45 1.34% 710.00 706.20 11,408 709.25 - 725.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
6M Average Volume: 103,882.37 P/B: 3.34 NSE Code: NATCOPHARM
52-Week Range: R 422.05 - 878.00 Dividend Yield: 0.56% BSE Code: 524816
TTM EPS: R 27.40 Book Value: R 214.49 Face Value: R 10
Price Graph
  • Astrazeneca Pharma India (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Natco Pharma -11.62 -13.28 -7.70 63.65 36.68 59.75 22.07
S&P BSE Small Cap 14.85 13.52 16.17 26.66 -5.10 13.74 13.64
S&P BSE Healthcare 5.40 3.02 3.33 24.53 19.53 28.30 15.82
Company's return has been calculated on basis of NSE's price.
As on Apr 17, 2014
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 26.12 13.09 15.05
Net Profit 12.68 11.17 9.64
EPS 19.70 9.79 9.66
Book Value 11.84 16.12 17.71
Average
Operating Margin 24.58 22.64 21.66
Net Margin 9.79 10.65 10.49
Return on Networth 13.08 14.34 15.88
Return on Investment 16.04 15.89 17.41
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 13.47 14.50 21.05
Operating Profit 21.40 7.86 53.05
Net Profit 13.15 29.30 180.10
EPS 13.15 29.30 180.10
TTM
Revenue 3.69 11.64 8.45
Operating Profit 2.22 20.91 13.85
Net Profit 8.18 17.41 22.13
EPS 8.18 17.41 22.13
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Natco Pharma 2,366.87 612.42 95.57 15.40 15.55 3.34 26.12
Astrazeneca Pharma India 2,635.38 454.74 -16.52 -3.57 -61.95 25.88 -
Jubilant Life Sciences 2,723.71 3,547.48 -48.12 -1.35 -2.29 1.03 -
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 04, 2014 NATCO Group Employee Welfare Trust  Sell Off Market 13,961 857.30 119.69
Feb 25, 2014 NATCO Gruop Employees Welfare Trust  Sell Off Market 10,443 795.25 83.05
Aug 30, 2013 Rajeev Nannapaneni  Sell Off Market 100,000 583.50 583.50
Aug 30, 2013 Rajeev Nannapannei  Sell Inter Se Transfer 100,000 583.50 583.50
Aug 30, 2013 Venkata Satya Swathi Kantamani  Buy Off Market 100,000 583.50 583.50
Fund Houses which are invested in the stock
Fund Mar-14 Dec-13 Sep-13 Jun-13 Mar-13
ICICI Prudential Mutual Fund 4.77 5.37 5.58 5.88 5.61
SBI Mutual Fund 2.66 2.73 2.89 1.65 -
L&T Mutual Fund 0.93 1.40 1.42 1.59 1.59
UTI Mutual Fund 0.25 0.24 0.24 0.24 0.24
Franklin Templeton Mutual Fund 0.18 0.18 0.30 0.83 0.30
DSP BlackRock Mutual Fund 0.18 0.85 1.09 0.38 0.38
Goldman Sachs Mutual Fund 0.02 0.03 - - -
Shriram Mutual Fund 0.00 0.00 - - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Natco Pharma Ltd.

Address: Natco House, Road No 2, Banjara Hills, Hyderabad, Andhra Pradesh - 500033 | Phone: +91-40- 23547532 | Fax: +91-40- 23548243

Email: investors@natcophrma.co.in

Website: www.natcopharma.co.in

Registrar & Transfer Agent: Venture Capital & Corporate Investments Ltd

Address: 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad | Phone: 91-40-23818475/6 | Fax: 91-40-23868024

Email: info@vccilindia.com